<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Vis</journal-id><journal-id journal-id-type="publisher-id">MV</journal-id><journal-title>Molecular Vision</journal-title><issn pub-type="epub">1090-0535</issn><publisher><publisher-name>Molecular Vision</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">124</article-id><article-id pub-id-type="publisher-id">2008MOLVIS0049</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title><italic>LOXL1</italic> genetic polymorphisms are associated with exfoliation glaucoma in the Japanese population</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mori</surname><given-names>Kazuhiko</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Imai</surname><given-names>Kojiro</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Matsuda</surname><given-names>Akira</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ikeda</surname><given-names>Yoko</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Naruse</surname><given-names>Shigeta</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hitora-Takeshita</surname><given-names>Hisako</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Nakano</surname><given-names>Masakazu</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Taniguchi</surname><given-names>Takazumi</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Omi</surname><given-names>Natsue</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Tashiro</surname><given-names>Kei</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kinoshita</surname><given-names>Shigeru</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><aff id="aff1"><label>1</label>Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan</aff><aff id="aff2"><label>2</label>Genomic Medical Sciences, Kyoto Prefectural University of Medicine, Kyoto, Japan</aff></contrib-group><author-notes><corresp id="cor1">Correspondence to: Akira Matsuda, Department of Ophthalmology, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Hirokoji-agaru, Kawaramachi-dori, Kamigyo-ku, Kyoto, 602-0841, Japan; Phone: +81-75-251-5578; FAX: +81-75-251-5663; email: <email xlink:href="akimatsu@ophth.kpu-m.ac.jp">akimatsu@ophth.kpu-m.ac.jp</email></corresp></author-notes><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>05</day><month>6</month><year>2008</year></pub-date><volume>14</volume><fpage>1037</fpage><lpage>1040</lpage><history><date date-type="received"><day>14</day><month>2</month><year>2008</year></date><date date-type="accepted"><day>30</day><month>5</month><year>2008</year></date></history><permissions><copyright-year>2008</copyright-year><copyright-holder>Molecular Vision</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><sec><title>Purpose</title><p>We performed genetic association studies using a native Japanese population to examine the reproducibility of results of <italic>lysyl oxidase-like 1</italic> (<italic>LOXL1</italic>) genetic association studies for exfoliation glaucoma (XFG) beyond the differences of ethnicity. We also quantified <italic>LOXL1</italic> mRNA expression in the human lens capsule to examine the possible correlation between <italic>LOXL1</italic> expression and XFG pathogenesis.</p></sec><sec sec-type="methods"><title>Methods</title><p>We performed a case-control study using 95 Japanese XFG patients and 190 controls. Real-time polymerase chain reaction (PCR) analysis was performed using lens capsules obtained during surgery.</p></sec><sec><title>Results</title><p>The TT genotype in the single nucleotide polymorphism (SNP) <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and the GG genotype in the SNP <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> in exon 1 of <italic>LOXL1</italic> were significantly associated with an increased risk of XFG under recessive models (&#x003c7;<sup>2</sup> test, p=5.34&#x000d7;10<sup>&#x02212;34</sup> and p=2.1&#x000d7;10<sup>&#x02212;8</sup>, respectively). Quantification of <italic>LOXL1</italic> mRNA expression demonstrated no significant difference between XFG and senile cataract samples.</p></sec><sec><title>Conclusions</title><p>Although the functional effects of the <italic>LOXL1</italic> SNP appear to be qualitative rather than quantitative, the amino acid substitution (R141L) caused by SNP <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> is not a simple decisive factor for XFG due to the inverted allele frequency between Japanese XFG and Caucasian XFG patients. Further genetic and functional studies are essential for clarifying XFG pathogenesis.</p></sec></abstract><custom-meta-wrap><custom-meta><meta-name>GalleyStatus</meta-name><meta-value>Export to XML</meta-value></custom-meta></custom-meta-wrap></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Exfoliation glaucoma (XFG) is an age-related disorder associated with exfoliation syndrome (XFS), manifested by abnormal fibrillar deposits on the lens and iris epithelium [<xref ref-type="bibr" rid="r1">1</xref>]. Recently, a genome wide association study performed for the Caucasian population revealed a strong association between the genotype of single genetic polymorphisms (SNPs) in the <italic>lysyl oxidase-like 1</italic> (<italic>LOXL1</italic>) gene and the occurrence of XFS/XFG [<xref ref-type="bibr" rid="r2">2</xref>]. It was reported that the rate of XFG occurrence significantly differed from one ethnic population to another [<xref ref-type="bibr" rid="r3">3</xref>], therefore it is logically important to perform a case-control study using another ethnic population such as the Japanese. In this study, we found a strong genetic association between the occurrence of XFG and the <italic>LOXL1</italic> single nucleotide polymorphism (SNP) genotype. One of the nonsynonymous SNP (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>) showed a very strong association with XFG. However, the risk allele was inverse compared to the Caucasian study. To gain further insight into the role of <italic>LOXL1</italic> for XFG, it is important to compare the expression levels of <italic>LOXL1</italic> mRNA in XFG eyes and non-glaucomatous eyes. We obtained anterior lens capsules during combined glaucoma-cataract surgery or during cataract surgery alone from XFG patients and non-glaucomatous senile cataract patients, respectively. We then performed a quantitative analysis of <italic>LOXL1</italic> mRNA expression using these anterior lens capsules.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Subjects</title><p>All XFG patients were diagnosed by slit-lamp examination for the existence of exfoliation material on the anterior lens capsule with maximal dilation of the pupils and with glaucomatous optic neuropathy as well as visual field defect. Peripheral blood was obtained from 95 XFG patients 47&#x02013;93 years of age (mean age: 75.7&#x000b1;8.1 years). The controls were 190 randomly-selected, population-based individuals 54&#x02013;83 years of age (mean age: 65.0&#x000b1;6.8 years) with no glaucomatous changes or existence of exfoliation materials (<xref ref-type="table" rid="t1">Table 1</xref>). All of the XFG patients and normal volunteers were recruited at Kyoto Prefectural University Hospital (Kyoto, Japan) and examined by glaucoma specialists using slit-lamp microscopy and an automated visual field analyzer. All study subjects were ethnically Japanese. According to the rules of the process committee at Kyoto Prefectural University of Medicine, written informed consent was obtained from all participants before participation in this genetic association study. The study was conducted in accordance with the tenets of the Declaration of Helsinki.</p><table-wrap id="t1" position="float"><label>Table 1</label><caption><title>Clinical characters of the exfoliation glaucoma patients and control.</title></caption><table frame="hsides" rules="groups"><col width="77" span="1"/><col width="72" span="1"/><col width="81" span="1"/><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>XFG</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>Control</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Total number of subjects<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">95<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">190<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Mean age (range)</td><td valign="top" align="center" rowspan="1" colspan="1">75.7 (47&#x02013;93 years)</td><td valign="top" align="center" rowspan="1" colspan="1">65.0 (54&#x02013;83 years)</td></tr></tbody></table><table-wrap-foot><p>Ninety-five exfoliation glaucoma patients 47 to 93 years of age (mean age: 75.7 years), and 190 randomly-selected population-based individuals 54 to 83 years of age (mean age: 65.0 years) with no glaucomatous changes or existence of exfoliation materials were involved in this study.</p></table-wrap-foot></table-wrap></sec><sec><title>Genotyping</title><p>We genotyped two nonsynonymous single nucleotide polymorphisms (SNPs; <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link>) in the <italic>LOXL1</italic> gene region according to the previous report [<xref ref-type="bibr" rid="r2">2</xref>]. We genotyped the SNPs with both direct sequencing and the TaqMan genotyping assay (Applied Biosystems, Foster City, CA). We used a set of primers (5&#x02032;-GAT CCA GTG GGA GAA CAA CG-3&#x02032; and 5&#x02032;-GGT ACT CGG GCA GCT CTT C-3&#x02032;) for direct sequencing. Genotyping was performed using on a 3130xl Sequence Detection System or with 7500 Realtime-time polymerase chain reaction (PCR) system (Applied Biosystems). The TaqMan genotyping assay was performed according to the manufacturer&#x02019;s protocol. All the genotyping procedures were approved by the ethics committee of Kyoto Prefectural University of Medicine.</p></sec><sec><title>Statistical analysis</title><p>The frequencies of the genotypes were compared between XFG patients and controls in the recessive model. In this model, frequencies of the homozygous genotype for major alleles were compared using a 2x2 contingency table. Here, the association was evaluated using the &#x003c7;<sup>2</sup> test for the contingency table. A p-value of less than 0.01 was considered to be statistically significant. Odds ratios (OR) and 95% confidence intervals (95% CI) were also calculated.</p></sec><sec><title>Real-time polymerase chain reaction analysis</title><p>Anterior capsules that were obtained during glaucoma/cataract or cataract surgery with written informed consent were immediately stored with RNAlater reagent (Ambion, Austin, TX) to protect the RNA. All procedures were approved by the ethics committee of Kyoto Prefectural University of Medicine. Total RNA was isolated with the Micro RNA extraction kit (Qiagen Japan, Tokyo, Japan) from the anterior capsules, and then cDNA was prepared as described previously [<xref ref-type="bibr" rid="r4">4</xref>]. The anterior capsules were obtained from 10 XFG patients undergoing combined (cataract+glaucoma) surgery (mean age 74.9&#x000b1;8.0 years; male:female=6:4) and 10 non-glaucomatous, senile cataract patients (mean age: 76.5&#x000b1;10.6 years; male:female=4:6). To avoid contamination of blood, anterior lens capsulotomy was performed before glaucoma surgery in cases of combined procedures. We used TaqMan real-time PCR probes and primers specific for human <italic>LOXL1</italic> (Hs00173746_m1), and 18S rRNA from Applied Biosystems (Assay-on-Demand gene expression products). Real-time PCR analysis was performed on a 7500 real-time PCR system. The relative expression of <italic>LOXL1</italic> mRNA in the anterior lens capsule was quantified by the standard curve method using 18S rRNA expression in the same cDNA as the control.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Case-control association study in the <italic>LOXL1</italic> gene region</title><p>We genotyped 95 XFG cases and 190 control subjects by direct sequencing methods. The <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> TT genotype and the <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> GG genotype in the first exon of <italic>LOXL1</italic> were significantly associated with an increased risk of XFG under recessive models (&#x003c7;<sup>2</sup> test, raw p value=5.34x10<sup>&#x02212;34</sup>, OR=321.3, 95% CI=43.5&#x02013;2373.2 and p=2.1x10<sup>&#x02212;8</sup>, OR=38.3, 95% CI=5.2&#x02013;281.6, respectively; <xref ref-type="table" rid="t2">Table 2</xref>). We further tested reproducibility of the genotyping by TaqMan genotyping assay and confirmed the genotyping results because the results of the <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> genotyping was not concordant with the Hardy&#x02013;Weinberg equilibrium (HWE). The results obtained by the two methods were identical.</p><table-wrap id="t2" position="float"><label>Table 2</label><caption><title>Case-control study of two nonsynonymous single nucleotide polymorphisms in <italic>LOXL1</italic>.</title></caption><table frame="hsides" rules="groups"><col width="68" span="1"/><col width="54" span="1"/><col width="54" span="1"/><col width="72" span="1"/><col width="54" span="1"/><col width="54" span="1"/><tbody><tr><td colspan="3" valign="top" align="center" scope="row" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>&#x02028; <bold>(R141L)*</bold><hr/></td><td colspan="3" valign="top" align="center" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link>&#x02028; <bold>(G153D)**</bold><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><bold>Genotype</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>Control</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>XFG</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>Genotype</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>Control</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>XFG</bold><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">GG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">33<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">GG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">135<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">94<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">GT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">114<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">GA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">53<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">TT</td><td valign="top" align="center" rowspan="1" colspan="1">43</td><td valign="top" align="center" rowspan="1" colspan="1">94</td><td valign="top" align="center" rowspan="1" colspan="1">AA</td><td valign="top" align="center" rowspan="1" colspan="1">2</td><td valign="top" align="center" rowspan="1" colspan="1">0</td></tr></tbody></table><table-wrap-foot><p>The <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> TT genotype and the <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> GG genotype were significantly associated with an increased risk of XFG under recessive models (&#x003c7;<sup>2</sup> test). The single asterisk indicates TT versus GT+GG, P value=5.34x10&#x02013;34, OR=321.3, and 95% CI=43.5&#x02013;2373.2, and the double asterisk indicates GG versus GA+AA, p=2.1x10&#x02013;8, OR=38.3, and 95% CI=5.2&#x02013;281.6.</p></table-wrap-foot></table-wrap></sec><sec><title>Haplotype analysis of <italic>LOXL1</italic> single nucleotide polymorphisms</title><p>First, we checked the state of linkage disequilibrium (LD) between <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> and found that those two SNPs are in a state of strong LD (<xref ref-type="table" rid="t3">Table 3</xref>). Next, we examined the distribution of two-locus haplotypes in the XFG and control samples (<xref ref-type="table" rid="t4">Table 4</xref>) using <ext-link ext-link-type="uri" xlink:href="http://www.broad.mit.edu/mpg/haploview/">Haploview</ext-link> [<xref ref-type="bibr" rid="r5">5</xref>] and PENHAPLO [<xref ref-type="bibr" rid="r6">6</xref>] software. Among the two-locus haplotypes of SNPs in exon 1 (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> G/T and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> G/A), the TG haplotype showed an increased risk for XFG (TG/TG versus others; p=6.87x10<sup>&#x02212;7</sup>, OR=312.162) in recessive models. We checked HWE among control subjects using this two-locus haplotype and found that the two-locus haplotype was concordant with HWE (p=0.0125, &#x003c7;<sup>2</sup> test).</p><table-wrap id="t3" position="float"><label>Table 3</label><caption><title>Linkage disequilibrium state of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link>.</title></caption><table frame="hsides" rules="groups"><col width="86" span="1"/><col width="27" span="1"/><col width="63" span="1"/><tbody><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><bold>SNP</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>D'</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>r2</bold><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Control+XFG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.243<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Control only<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.196<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">XFG only</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">1</td></tr></tbody></table><table-wrap-foot><p>We calculated the state of linkage disequilibrium between <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> among the control population, XFG population, and total population. Linkage disequilibrium coefficients were expressed as D' or r2.</p></table-wrap-foot></table-wrap><table-wrap id="t4" position="float"><label>Table 4</label><caption><title>Structures and frequency of two locus haplotype.</title></caption><table frame="hsides" rules="groups"><col width="68" span="1"/><col width="54" span="1"/><col width="63" span="1"/><tbody><tr><td rowspan="2" valign="top" align="center" scope="row" colspan="1"><bold>Haplotype</bold><hr/></td><td colspan="2" valign="top" align="center" rowspan="1"><bold>Frequency</bold><hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1"><bold>Case</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>Control</bold><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">TG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.9947<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.5263<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">GG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.3237<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">GA</td><td valign="top" align="center" rowspan="1" colspan="1">0.0053</td><td valign="top" align="center" rowspan="1" colspan="1">0.15</td></tr></tbody></table><table-wrap-foot><p>We examined the frequency of two-locus haplotypes in the XFG and control samples using <ext-link ext-link-type="uri" xlink:href="http://www.broad.mit.edu/mpg/haploview/">Haploview</ext-link> and PENHAPLO software. The TG haplotype means <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>-T and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link>-G, the GG haplotype means <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>-G and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link>-G, and the GA haplotype means <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>-G and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link>-A.</p></table-wrap-foot></table-wrap></sec><sec><title><italic>LOXL1</italic> mRNA quantification using anterior lens capsules</title><p>cDNA was synthesized from total RNA isolated from the anterior lens capsules of patients undergoing cataract surgery. We analyzed both XFG (n=10) and senile cataract (n=10) specimens. <xref ref-type="fig" rid="f1">Figure 1</xref> is a representative result of two independent results of experiments run in duplicate. There was no statistically significant difference between the expression levels of <italic>LOXL1</italic> mRNA in the lens epithelium obtained from XFG patients and senile cataract patients. (<xref ref-type="fig" rid="f1">Figure 1</xref>, p=0.529 by the Mann&#x02013;Whitney U<italic>-</italic>test)</p><fig id="f1" fig-type="figure" position="float"><label>Figure 1</label><caption><p>Real-time polymerase chain reaction analysis of <italic>LOXL1</italic> mRNA expression in anterior lens capsules. Total RNA was extracted from the anterior lens capsule of XFG/senile cataracts. Real-time PCR analysis was performed with expression assay probes. The amount of relative expression was normalized to that of 18Sr RNA. (N.S.: Not statistically significant, p=0.529; Mann&#x02013;Whitney&#x02019;s U-test).</p></caption><graphic xlink:href="mv-v14-1037-f1"/></fig></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Similar to previous studies among Caucasian [<xref ref-type="bibr" rid="r2">2</xref>,<xref ref-type="bibr" rid="r7">7</xref>,<xref ref-type="bibr" rid="r8">8</xref>], we found a strong genetic association between the <italic>LOXL1</italic> SNP and XFG patients. The lysyl oxidase protein family has multiple functions including specific oxidative deamination of lysine residues and the cross-linking of elastin [<xref ref-type="bibr" rid="r9">9</xref>]. Phenotypic analysis of <italic>LOXL1</italic> knockout mice [<xref ref-type="bibr" rid="r10">10</xref>] showed that the LOXL1 protein has an essential role for the homeostasis of elastic fibers, which also contribute to the trabecular meshwork structures [<xref ref-type="bibr" rid="r11">11</xref>]. Therefore, it is functionally reasonable to assume that <italic>LOXL1</italic> is one of the causative genes for XFG.</p><p>For the <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> genotype, our results are consistent with those of Thorleifsson et al. [<xref ref-type="bibr" rid="r2">2</xref>]. The allele frequency of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> G is consistently higher among Caucasian and Japanese XFG patients so it is reasonable to conclude that <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> A is a protective allele against the occurrence of XFG.</p><p>On the other hand, the risk allele for XFG occurrence is <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>-&#x0201c;T&#x0201d; among the Japanese population and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>-&#x0201c;G&#x0201d; among the Caucasian population. We double-checked these genotype results (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link>) by both direct sequencing and the TaqMan genotyping assay because the genotype results of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> within control subjects were not concordant with HWE. The results obtained from two different methods were in complete agreement. Therefore non-concordance with HWE is not due to genotyping errors. We further checked the two-locus haplotype and found that the haplotype was concordant with HWE. Since the two-locus, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942">rs3825942</ext-link>, was in the state of linkage disequilibrium (D&#x02019;=1.0), it was appropriate to check the HWE by haplotype.</p><p>Inverted genotypes of XFG patients between the Japanese and Caucasian population suggests the following possibilities: (1) The 141st amino acid substitution (R141L) does not have a dominant role for the pathophysiology of XFG, (2) the heterozygote for the <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> G/T genotype may have a protective role against XFG occurrence, or (3) there might be another causative polymorphism in a state of linkage disequilibrium with <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> G/T. If the last possibility is the case, there might be a historical recombination between the SNP <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> and the causative polymorphism.</p><p>As a next step, we quantified relative <italic>LOXL1</italic> mRNA expression in anterior lens capsules and found that there was no significant difference between XFG and senile cataract controls. These results are different from the previous study by Thorleifsson et al. [<xref ref-type="bibr" rid="r2">2</xref>], which showed a significantly higher <italic>LOXL1</italic> mRNA expression with the TT genotype (the protective genotype against XFG in the Caucasian population) than those with the TG or GG genotype using adipose tissues. We hypothesize that the difference might be due to the mixed <italic>LOXL1</italic> SNP genotype of our senile cataract surgery samples, which are not able to clarify genotype due to ethical procedure reasons. However, our <italic>LOXL1</italic> mRNA expression analysis reflects a direct pathological site within the ocular tissue and better represents <italic>LOXL1</italic> expression status in the affected eyes than that of adipose tissue [<xref ref-type="bibr" rid="r2">2</xref>]. Therefore, we deduced that it is likely that the quantitative difference of <italic>LOXL1</italic> mRNA is not a direct pathogenetic cause of XFG.</p><p>To further clarify the pathophysiological role of <italic>LOXL1</italic> for XFG, we are now performing extensive SNP discovery around <italic>LOXL1</italic> to find out other possible causative polymorphisms. In addition, functional analysis of LOXL1-fibulin5 protein interaction [<xref ref-type="bibr" rid="r12">12</xref>] using two types of recombinant LOXL1 precursor protein (141R and 141L) is ongoing. Since LOXL1-fibulin5 interaction is essential for mature cross-linked elastin formation [<xref ref-type="bibr" rid="r10">10</xref>,<xref ref-type="bibr" rid="r12">12</xref>], we are focused on determining the role of the two variants of <italic>LOXL1</italic> and its mixture to gain further insight into our genetic association results showing that the <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661">rs1048661</ext-link> G/T heterozygote is protective against XFG. It is also important to investigate the protective role of LOXL1 protein variants that possess the 153D amino acid, which is indicated by multiple genetic association studies including our own [<xref ref-type="bibr" rid="r2">2</xref>,<xref ref-type="bibr" rid="r7">7</xref>,<xref ref-type="bibr" rid="r8">8</xref>] as well as to analyze the possible role of the pairs of 141/153 amino acid variants in consideration of our haplotype analysis result.</p></sec></body><back><ack><title>Acknowledgments</title><p>This study was supported by grants-in-aid for Scientific Research (programs 18890164, 14657449, and 18659516) from the Japanese Ministry of Education, Culture, Sports, Science and Technology. We thank Dr. Shigeo Kamitsuji (Stagen. Co. Ltd., Tokyo, Japan) for statistical analysis and Mr. John Bush for English language editing. During the submission process of this manuscript, Hayashi et al. published a LOXL1 genetic association study using a Japanese XFS population (Am J Ophthalmol 2008;145:582&#x02013;585).</p></ack><ref-list><title>References</title><ref id="r1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schlotzer-Schrehardt</surname><given-names>U</given-names></name><name><surname>Naumann</surname><given-names>GO</given-names></name></person-group><article-title>Ocular and systemic pseudoexfoliation syndrome.</article-title><source>Am J Ophthalmol</source><year>2006</year><volume>141</volume><fpage>921</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">16678509</pub-id></citation></ref><ref id="r2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Magnusson</surname><given-names>KP</given-names></name><name><surname>Sulem</surname><given-names>P</given-names></name><name><surname>Walters</surname><given-names>GB</given-names></name><name><surname>Gudbjartsson</surname><given-names>DF</given-names></name><name><surname>Stefansson</surname><given-names>H</given-names></name><name><surname>Jonsson</surname><given-names>T</given-names></name><name><surname>Jonasdottir</surname><given-names>A</given-names></name><name><surname>Jonasdottir</surname><given-names>A</given-names></name><name><surname>Stefansdottir</surname><given-names>G</given-names></name><name><surname>Masson</surname><given-names>G</given-names></name><name><surname>Hardarson</surname><given-names>GA</given-names></name><name><surname>Petursson</surname><given-names>H</given-names></name><name><surname>Arnarsson</surname><given-names>A</given-names></name><name><surname>Motallebipour</surname><given-names>M</given-names></name><name><surname>Wallerman</surname><given-names>O</given-names></name><name><surname>Wadelius</surname><given-names>C</given-names></name><name><surname>Gulcher</surname><given-names>JR</given-names></name><name><surname>Thorsteingsdottir</surname><given-names>U</given-names></name><name><surname>Kong</surname><given-names>A</given-names></name><name><surname>Jonasson</surname><given-names>F</given-names></name><name><surname>Stefanssoon</surname><given-names>K</given-names></name></person-group><article-title>Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma.</article-title><source>Science</source><year>2007</year><volume>317</volume><fpage>1397</fpage><lpage>400</lpage><pub-id pub-id-type="pmid">17690259</pub-id></citation></ref><ref id="r3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Forsius</surname><given-names>H</given-names></name><name><surname>Forsman</surname><given-names>E</given-names></name><name><surname>Fellman</surname><given-names>J</given-names></name><name><surname>Eriksson</surname><given-names>AW</given-names></name></person-group><article-title>Exfoliation syndrome: frequency, gender distribution and association with climatically induced alterations of the cornea and conjunctiva.</article-title><source>Acta Ophthalmol Scand</source><year>2002</year><volume>80</volume><fpage>478</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">12390157</pub-id></citation></ref><ref id="r4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsuda</surname><given-names>A</given-names></name><name><surname>Ebihara</surname><given-names>N</given-names></name><name><surname>Kumagai</surname><given-names>N</given-names></name><name><surname>Fukuda</surname><given-names>K</given-names></name><name><surname>Ebe</surname><given-names>K</given-names></name><name><surname>Hirano</surname><given-names>K</given-names></name><name><surname>Sotozono</surname><given-names>C</given-names></name><name><surname>Tei</surname><given-names>M</given-names></name><name><surname>Hasegawa</surname><given-names>K</given-names></name><name><surname>Shimizu</surname><given-names>M</given-names></name><name><surname>Tamari</surname><given-names>M</given-names></name><name><surname>Namba</surname><given-names>K</given-names></name><name><surname>Ohno</surname><given-names>S</given-names></name><name><surname>Mizuki</surname><given-names>N</given-names></name><name><surname>Ikezawa</surname><given-names>Z</given-names></name><name><surname>Shirakawa</surname><given-names>T</given-names></name><name><surname>Hamuro</surname><given-names>J</given-names></name><name><surname>Kinoshita</surname><given-names>S</given-names></name></person-group><article-title>Genetic polymorphisms in the promoter of the interferon gamma receptor 1 gene are associated with atopic cataracts.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2007</year><volume>48</volume><fpage>583</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17251453</pub-id></citation></ref><ref id="r5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>JC</given-names></name><name><surname>Fry</surname><given-names>B</given-names></name><name><surname>Maller</surname><given-names>J</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name></person-group><article-title>Haploview: analysis and visualization of LD and haplotype maps.</article-title><source>Bioinformatics</source><year>2005</year><volume>21</volume><fpage>263</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">15297300</pub-id></citation></ref><ref id="r6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>T</given-names></name><name><surname>Inoue</surname><given-names>E</given-names></name><name><surname>Kamatani</surname><given-names>N</given-names></name></person-group><article-title>Association test algorithm between a qualitative phenotype and a haplotype or haplotype set using simultaneous estimation of haplotype frequencies, diplotype configurations and diplotype-based penetrances.</article-title><source>Genetics</source><year>2004</year><volume>168</volume><fpage>2339</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">15611197</pub-id></citation></ref><ref id="r7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hewitt</surname><given-names>AW</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Burdon</surname><given-names>KP</given-names></name><name><surname>Wang</surname><given-names>JJ</given-names></name><name><surname>Baird</surname><given-names>PN</given-names></name><name><surname>Dimasi</surname><given-names>DP</given-names></name><name><surname>Mackey</surname><given-names>DA</given-names></name><name><surname>Mitchell</surname><given-names>P</given-names></name><name><surname>Craig</surname><given-names>JE</given-names></name></person-group><article-title>Ancestral LOXL1 variants are associated with pseudoexfoliation in Caucasian Australians but with markedly lower penetrance than in Nordic people.</article-title><source>Hum Mol Genet</source><year>2007</year><volume>17</volume><fpage>710</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">18037624</pub-id></citation></ref><ref id="r8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fingert</surname><given-names>JH</given-names></name><name><surname>Alward</surname><given-names>WL</given-names></name><name><surname>Kwon</surname><given-names>YH</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Streb</surname><given-names>LM</given-names></name><name><surname>Sheffield</surname><given-names>VC</given-names></name><name><surname>Stone</surname><given-names>EM</given-names></name></person-group><article-title>LOXL1 mutations are associated with exfoliation syndrome in patients from the midwestern United States.</article-title><source>Am J Ophthalmol</source><year>2007</year><volume>144</volume><fpage>974</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">18036875</pub-id></citation></ref><ref id="r9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lucero</surname><given-names>HA</given-names></name><name><surname>Kagan</surname><given-names>HM</given-names></name></person-group><article-title>Lysyl oxidase: an oxidative enzyme and effector of cell function.</article-title><source>Cell Mol Life Sci</source><year>2006</year><volume>63</volume><fpage>2304</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">16909208</pub-id></citation></ref><ref id="r10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Pawlyk</surname><given-names>B</given-names></name><name><surname>Starcher</surname><given-names>B</given-names></name><name><surname>Spencer</surname><given-names>JA</given-names></name><name><surname>Yanagisawa</surname><given-names>H</given-names></name><name><surname>Zuo</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>T</given-names></name></person-group><article-title>Elastic fiber homeostasis requires lysyl oxidase-like 1 protein.</article-title><source>Nat Genet</source><year>2004</year><volume>36</volume><fpage>178</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">14745449</pub-id></citation></ref><ref id="r11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Umihira</surname><given-names>J</given-names></name><name><surname>Nagata</surname><given-names>S</given-names></name><name><surname>Nohara</surname><given-names>M</given-names></name><name><surname>Hanai</surname><given-names>T</given-names></name><name><surname>Usuda</surname><given-names>N</given-names></name><name><surname>Segawa</surname><given-names>K</given-names></name></person-group><article-title>Localization of elastin in the normal and glaucomatous human trabecular meshwork.</article-title><source>Invest Ophthalmol Vis Sci</source><year>1994</year><volume>35</volume><fpage>486</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">8112998</pub-id></citation></ref><ref id="r12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hirai</surname><given-names>M</given-names></name><name><surname>Ohbayashi</surname><given-names>T</given-names></name><name><surname>Horiguchi</surname><given-names>M</given-names></name><name><surname>Okawa</surname><given-names>K</given-names></name><name><surname>Hagiwara</surname><given-names>A</given-names></name><name><surname>Chien</surname><given-names>KR</given-names></name><name><surname>Kita</surname><given-names>T</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name></person-group><article-title>Fibulin-5/DANCE has an elastogenic organizer activity that is abrogated by proteolytic cleavage in vivo.</article-title><source>J Cell Biol</source><year>2007</year><volume>176</volume><fpage>1061</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">17371835</pub-id></citation></ref></ref-list></back></article> 